Home / Stocks / Makers Laboratories Ltd.
MAKERSL

Makers Laboratories Ltd. Share Price

Live price, chart and which mutual funds hold this stock

…

as of —

₹—

Change

—

Day Open

₹—

Day High

₹—

Day Low

₹—

NSE Close — 19 Nov 2026

₹268.67

Change

-9.59 (-3.45%)

Open

₹265.55

Prev. Close

₹278.26

Day High

₹284.55

Day Low

₹264.55

Volume Analysis

Traded

5,016

Delivered

52,730

Delivery %

36.36%

End-of-day NSE price via the official Bhavcopy — updated once daily after market close, not a live tick.

Strengths, Weaknesses, Opportunities & Threats

Strengths (0)

No signal for this stock

Weaknesses (1)

  • •Low return on equity (3.17%)

Opportunities (0)

No signal for this stock

Threats (0)

No signal for this stock

Rule-based signals from the fundamentals below — not investment advice.

Pivot Levels

Type R3 R2 R1 Pivot S1 S2 S3
Classic ₹300.63 ₹292.59 ₹280.63 ₹272.59 ₹260.63 ₹252.59 ₹240.63
Fibonacci ₹292.59 ₹284.95 ₹280.23 ₹272.59 ₹264.95 ₹260.23 ₹252.59
Camarilla ₹274.17 ₹272.34 ₹270.5 ₹272.59 ₹266.84 ₹265.0 ₹263.17

Support/resistance levels for today, calculated from the previous trading day's high/low/close.

Absolute Returns

YTD

—

1 Week

-15.22%

1 Month

+35.69%

3 Months

+43.77%

6 Months

—

1 Year

—

2Y/3Y/5Y not shown yet — price history tracking only goes back to mid-2025 so far.

Stock Vitals

Computed from the latest available annual financials.

DuPont ROE Breakdown

13.27%

Net margin 11.73% × asset turnover 0.69x × equity multiplier 1.64x

Company Overview

Sector

Healthcare

Market Cap

₹169 Cr

P/E (TTM)

22.6

ROE

3.17%

Book Value

₹133.0

Face Value

₹10.0

Source: Screener.in (Consolidated figures) — data as of 16 Nov 2026. Not investment advice.

TopFund Analysis

Makers Laboratories Ltd. lands in the middle of the pack on TopFund's composite fundamentals check within the Healthcare sector, at 62/100. The strongest factor is Financial Strength (100/100), while Liquidity (16/100) is the weakest area to weigh before deciding. Notably: Low return on equity (3.17%).

TopFund Score — Fundamentals Quality

62/100 — Average

Data confidence: 75/100 (Moderate Confidence) — based on how complete and how fresh the underlying data is.

As of 19 Nov 2026 · How we calculate this →

Financial Strength

100

Growth

68

Valuation

66

Cash Flow

48

Corporate Governance

56

Momentum

78

Institutional Ownership

30

Business Quality

56

Risk & Volatility

62

Liquidity

16

From Screener.in

  • +Company has reduced debt.
  • +Company is almost debt free.
  • +Company has delivered good profit growth of 49.3% CAGR over last 5 years
  • +Debtor days have improved from 68.8 to 51.6 days.
  • −Though the company is reporting repeated profits, it is not paying out dividend
  • −Company has a low return on equity of -2.05% over last 3 years.

Not investment advice — an automated read of public fundamentals data, for research context only.

Corporate Actions

Source: BSE regulatory filings, via Screener.in.

Quarterly Results

Last several quarters

  Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026 Sep 2026
Sales + 25 27 28 30 30 28 34 35 34 36 36 43 48
Expenses + 25 26 27 28 27 26 31 32 32 32 30 36 36
Operating Profit 0 0 1 2 2 1 3 3 2 4 5 7 12
OPM % 0.8% 0.75% 3.09% 6.12% 7.41% 4.73% 9.12% 8.6% 6.67% 11.66% 14.77% 16.27% 25.12%
Other Income + 0 0 0 -1 11 1 0 0 0 0 1 1 1
Interest 0 1 1 0 0 0 0 0 0 0 0 0 0
Depreciation 1 1 1 1 1 1 1 1 1 1 1 1 1
Profit before tax -1 -1 0 0 11 1 2 2 1 3 5 6 12
Tax % 10.89% -4.46% 152.63% 48.94% 11.98% 60.29% 24.64% 34.85% 42.64% 27.94% 24.89% 27.03% 26.15%
Net Profit + -1 -1 -1 -1 10 0 2 1 1 2 4 5 9
EPS in Rs -2 -3 -2 -2 15 -1 0 1 0 2 2 3 7
Raw PDF — — — — — — — — — — — — —
YoY Sales growth -5 33 -6 18 18 4 22 18 16 29 5 22 41

Source: Screener.in — figures in ₹ Crores unless marked %.

Profit & Loss (Yearly)

  Mar 2015 (S) Mar 2016 (S) Mar 2017 (S) Mar 2018 (S) Mar 2019 (S) Mar 2020 (S) Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 TTM
Sales + 65 61 58 56 47 51 69 127 101 104 121 141 162
Expenses + 61 57 53 51 44 49 60 108 98 103 112 126 134
Operating Profit 4 5 5 5 2 3 8 19 3 1 9 15 29
OPM % 7.0% 8.0% 9.0% 8.0% 4.8% 5.0% 12.0% 15.0% 3.3% 1.1% 7.0% 11.0% 18.0%
Other Income + 1 0 1 2 3 0 1 3 2 2 11 2 2
Interest 0 0 0 0 0 1 2 2 2 2 1 1 1
Depreciation 2 1 1 2 2 2 5 4 4 5 5 5 5
Profit before tax 3 4 5 4 3 0 3 16 -1 -4 13 11 26
Tax % 31.0% 34.0% 31.0% 28.0% 19.0% 148.0% 50.0% 25.0% 161.0% 23.0% 19.0% 30.0% —
Net Profit + 2 2 4 3 2 0 1 12 -2 -5 11 8 19
EPS in Rs 5 5 7 6 5 0 -1 8 -8 -11 13 4 13
Dividend Payout % 21.0% 21.0% 13.0% 16.0% 20.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% —
Sales growth -5 -5 -5 -4 -17 10 — 85 -20 2 16 16 24

Source: Screener.in — figures in ₹ Crores unless marked %.

Balance Sheet

  Mar 2015 (S) Mar 2016 (S) Mar 2017 (S) Mar 2018 (S) Mar 2019 (S) Mar 2020 (S) Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 Sep 2026
Reserves 20 21 29 32 37 40 49 55 63 57 65 67 72
Borrowings + 1 0 1 1 6 13 21 23 17 22 8 9 4
Other Liabilities + 14 14 15 15 12 16 62 62 66 76 70 85 99
Total Liabilities 39 40 50 53 60 74 136 144 152 161 148 167 182
Fixed Assets + 11 10 17 17 18 33 71 68 85 87 74 71 72
CWIP 3 4 0 0 6 1 0 9 0 0 1 4 1
Investments 2 2 7 9 11 15 2 0 0 3 0 12 21
Other Assets + 23 23 26 27 24 25 63 66 67 71 73 81 88
Total Assets 39 40 50 53 60 74 136 144 152 161 148 167 182
Equity Capital 5 5 5 5 5 5 5 5 6 6 6 6 6

Source: Screener.in — figures in ₹ Crores unless marked %.

Cash Flow

  Mar 2015 (S) Mar 2016 (S) Mar 2017 (S) Mar 2018 (S) Mar 2019 (S) Mar 2020 (S) Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Cash from Operating Activity + 1 4 6 0 5 4 0 18 -9 1 -4 14
Cash from Investing Activity + -1 -1 -3 -2 -8 -8 0 -22 1 -7 20 -15
Cash from Financing Activity + 0 -1 0 -1 4 3 0 0 6 6 -16 0
Net Cash Flow 0 1 3 -3 1 -1 0 -3 -2 0 0 0
Free Cash Flow -1 1 2 -2 -4 -4 0 9 -21 -6 11 11
CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit 40 100 128 34 283 155 0 128 -185 232 -20 118

Source: Screener.in — figures in ₹ Crores unless marked %.

Shareholding Pattern

Quarter-by-quarter — Promoters, FII, DII & public holding trend

Promoter holding: 61.28% → 61.28%
  Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026 Sep 2026
Public 38.74% 38.73% 38.74% 38.73% 38.33% 38.34% 38.35% 38.35% 38.35% 38.34% 38.34% 38.33%
Promoters 61.28% 61.28% 61.28% 61.28% 61.28% 61.28% 61.28% 61.28% 61.28% 61.28% 61.28% 61.28%
DII 0.0% 0.0% 0.0% 0.0% 0.39% 0.39% 0.39% 0.39% 0.39% 0.39% 0.39% 0.39%

Source: Screener.in — quarterly shareholding disclosures.

Peers Comparison

Healthcare — ranked by market cap

Company Market Cap (Cr) P/E P/B ROE
Makers Laboratories Ltd. (this stock) 169 22.6 2.15 3.17%
Balaxi Pharma Ltd 175 51.8 0.69 0.59%
Take Limited 192 22.0 5.6 16.5%
Nectar Lifesciences Ltd. 193 — 0.34 -31.3%
Natural Capsules Limited 144 — 0.66 -9.45%
Bilcare Ltd. 202 5.55 1.13 1.39%
Brooks Lab Limited 203 58.7 1.08 22.0%

Which Mutual Funds Hold Makers Laboratories Ltd.?

Frequently Asked Questions about Makers Laboratories Ltd.

Community Sentiment

What are other investors saying about Makers Laboratories Ltd.?

No votes yet — be the first to share your view.

Sign in to vote

Discussion

User-generated content — not investment advice, and not verified or endorsed by TopFund.

Sign in to join the discussion

No comments yet — start the discussion.